David DeRemer, PharmD, BCOP, FCCP, FHOPA, Clinical Associate Professor, University of Florida College of Pharmacy, shares insights about cancer drugs and COVID-19 in this interview that followed a segment of the Association for Value-Based Cancer Care (AVBCC) webinar series COVID-19 Recovery, the Road Ahead, in which he recently took part.
The COVID-19 pandemic will have far-reaching economic implications in the United States and abroad for the foreseeable future. During this session, Murray Aitken, MBA, Director, IQVIA Institute, presented emerging data regarding some of the ways in which the pandemic is affecting the US economy.
Burt Zweigenhaft, PhD, D.Litt, Founder, Association for Value-Based Cancer Care, moderated a panel session in which 3 experts from the independent actuarial firm, Milliman, discussed recent data showing the ways in which the COVID-19 pandemic may affect the future of healthcare.
The federal government is an active participant in shaping and delivering healthcare policy. The panelists in this session addressed the government’s response to COVID-19 and weighed in on some of the issues that their agencies frequently encountered as medical practices grapple with the new normal.
Nurses are on the front lines like no other healthcare personnel. In this panel, distinguished nursing professionals discussed topics and issues that have arisen during the pandemic. Led by healthcare educator Lillie D. Shockney, the comprehensive panel covered some of the myriad issues nurse navigators confront now, including rising cancer rates in an aging population, and a decline in numbers of oncology nurses and oncologists.
Researchers and clinical investigators are facing a series of unprecedented challenges as they adjust to necessary changes to their work environment resulting from the COVID-19 crisis. In this discussion, moderated by Rob Butcher, CEO, Swim Across America, a panel of researchers discuss the impact of the pandemic on conditions in laboratories, and how graduate students have had to adjust to interruptions in their career trajectories.
Telehealth continues to play a critical role in providing healthcare services to patients during the COVID-19 pandemic. In a webcast titled COVID-19: Impact on Telehealth, Rick Lee, Executive Chairman, Healthy Platforms and CancerLife, along with a panel of experts, discussed the benefits and ongoing challenges associated with the use of telemedicine and the far-reaching impact of this technology beyond the current crisis.
Employers continue to face significant challenges as they strive to provide healthcare coverage for their employees during the COVID-19 pandemic. In this discussion, moderated by Burt Zweigenhaft, PhD, D.Litt, a panel of experts explore solutions for some of the issues arising in a vastly changed healthcare market, and strategies for improving the way in which health benefits are conceived and implemented.
Pharmaceutical support and innovation are vital to the effective treatment of patients with cancer. In this discussion, moderated by Burt Zweigenhaft, PhD, D.Litt, a panel of experts discussed the importance of maintaining an adequate supply of medicines for patients, and the need for philanthropic programs to ensure patients will be able to continue their medications, even if they lose their health insurance.
In this discussion, moderated by Niesha Griffith, RPh, MS, FASHP, CPO (interim), a panel of oncology pharmacists discuss the impact of the COVID-19 pandemic on their practices, the increase in the use of new technologies as a result of recent events, and how the influx of patients expected in the coming weeks will affect their daily operations.
Page 1 of 3
Results 1 - 10 of 25
Results 1 - 10 of 25